TrialLeukemia2016

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).

E Schuler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.